Evidence map›Paper›PMID 41356335›Full record

ReviewClinical parkinsonism & related disorders2025

Can Parkinsonism be a solitary manifestation of Wilson's Disease?

Mehri Salari, Fatemeh Hojjatipour, Kamran Rezaei, Masoud Etemadifar

Abstract readReview
In one paragraph

Review in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mehri SalariNeurology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fatemeh HojjatipourSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kamran RezaeiSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Masoud EtemadifarNeurology Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease (WD) is a secondary parkinsonian condition that results in multi-organ dysfunction. Accurately diagnosing this disorder as soon as possible is crucial since it is a treatable condition. In order to diagnose WD, a doctor must be aware of the disorder's early signs and request the following diagnostic tests. These include serum ceruloplasmin levels, 24-hour urinary copper excretion, slit-lamp examination for Kayser-Fleischer rings, liver biopsy, and ATP7B genetic testing when needed. It is mentioned that WD can present with a wide range of manifestations; however, according to our observations of thoroughly analyzing cases and papers concerning WD patients, we conclude that parkinsonism cannot be the only early symptom of WD. Most patients who developed parkinsonian symptoms also showed accompanying features such as dysarthria, dystonia, or behavioral changes. This finding would assist doctors in rolling out WD diagnosis and focusing on other potential diseases. By avoiding unnecessary investigations for WD in cases of isolated, typical parkinsonism, physicians can more effectively allocate resources and explore other more probable differential diagnoses. This situation allows for earlier initiation of appropriate therapy tailored to the correct underlying condition, and the overall financial burden on individuals and health systems would be lessened. Such an approach would also help reduce patient anxiety caused by uncertainty.

Indexed as

Idiopathic Parkinson’s DiseaseParkinsonismTremorWilson’s Disease

Identifiers

PMID41356335
PMCPMC12677078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.